SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-13-448057
Filing Date
2013-11-20
Accepted
2013-11-20 12:02:29
Documents
1
Group Members
CLARUS VENTURES II GP, L.P.CLARUS VENTURES II, LLCDENNIS HENNERKURT WHEELERMICHAEL STEINMETZNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAK

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d629402dsc13d.htm SC 13D 192778
  Complete submission text file 0001193125-13-448057.txt   194550
Mailing Address 5 VAUGHN DRIVE SUITE 106 PRINCETON NJ 08540
Business Address 5 VAUGHN DRIVE SUITE 106 PRINCETON NJ 08540 609-945-6050
Ophthotech Corp. (Subject) CIK: 0001410939 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87636 | Film No.: 131232234
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences II, L.P. (Filed by) CIK: 0001431443 (see all company filings)

IRS No.: 261856183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D